A Robust Biprotein Stabilized Pericardium Valve Material Priming Resistance to Calcification

Area of Science:

• Biomaterials Science
• Cardiovascular Research
• Tissue Engineering

Background:

• Severe calcific aortic valve disease (CAVD) affects a significant portion of the elderly population.
• Current valve replacement relies on pericardium-based bioprosthetics, which are prone to recalcification.
• Glutaraldehyde cross-linking limitations lead to residual aldehydes and inadequate elastin stabilization, causing clinical challenges.

Purpose of the Study:

• To develop a novel biprotein stabilized pericardium material (CHPP) to overcome the limitations of current bioprosthetic heart valves.
• To enhance the stability, biocompatibility, and anticalcification properties of pericardium-based materials.
• To investigate the potential of CHPP in creating an immune-privileged microenvironment for improved valve performance.

Main Methods:

• Development of a biprotein material (CHPP) using collagen and elastin cross-linked by procyanidins (PC) with 3,4-hydroxyphenylpropionic acid (HPA).
• Assessment of material stability against enzymatic attack and evaluation of biocompatibility and platelet absorption.
• In vivo studies to evaluate structural preservation, immune response modulation (macrophages, T cells), and anticalcification capacity.

Main Results:

• CHPP demonstrated improved stability, enhanced biocompatibility, and minimized platelet absorption compared to conventional materials.
• The material significantly resisted calcification, attributed to stabilized biprotein components and reduced inflammatory responses.
• In vivo studies confirmed structural integrity and the establishment of an immune-privileged microenvironment, reducing macrophage and T cell infiltration.

Conclusions:

• Procyanidin-assisted cross-linking of collagen and elastin in pericardium creates a robust, immune-tolerant material (CHPP).
• CHPP exhibits significant anticalcification properties, addressing a major clinical challenge in bioprosthetic heart valves.
• This approach offers a promising alternative for generating advanced, long-lasting valve materials with enhanced calcification resistance.